Total Payments
$362,343
2024 Payments
$40,084
Companies
74
Transactions
1,458
Medicare Patients
29,060
Medicare Billing
$4.2M
Payment Breakdown by Category
Other$262,617 (72.5%)
Travel$41,273 (11.4%)
Food & Beverage$35,581 (9.8%)
Consulting$21,126 (5.8%)
Research$1,500 (0.4%)
Education$245.15 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $180,407 | 96 | 49.8% |
| Honoraria | $82,210 | 35 | 22.7% |
| Travel and Lodging | $41,273 | 104 | 11.4% |
| Food and Beverage | $35,581 | 1,198 | 9.8% |
| Consulting Fee | $21,126 | 8 | 5.8% |
| Unspecified | $1,500 | 1 | 0.4% |
| Education | $245.15 | 16 | 0.1% |
Payments by Type
General
$360,843
1,457 transactions
Research
$1,500
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $168,265 | 294 | $0 (2024) |
| Lundbeck LLC | $118,370 | 145 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $12,714 | 40 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $10,035 | 36 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $8,491 | 95 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $6,435 | 65 | $0 (2024) |
| PFIZER INC. | $5,916 | 48 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $4,739 | 16 | $0 (2021) |
| Medtronic Vascular, Inc. | $4,133 | 44 | $0 (2020) |
| Medtronic, Inc. | $2,270 | 54 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $40,084 | 125 | Amgen Inc. ($37,848) |
| 2023 | $45,841 | 166 | Amgen Inc. ($42,890) |
| 2022 | $24,355 | 139 | Amgen Inc. ($21,661) |
| 2021 | $13,173 | 151 | Amgen Inc. ($8,106) |
| 2020 | $22,857 | 132 | Lundbeck LLC ($11,608) |
| 2019 | $48,880 | 224 | Lundbeck LLC ($18,152) |
| 2018 | $103,408 | 276 | Lundbeck LLC ($75,924) |
| 2017 | $63,745 | 245 | Amgen Inc. ($25,911) |
All Payment Transactions
1,458 individual payment records from CMS Open Payments — Page 1 of 59
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $33.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | Philips North America LLC | (CQ0) Azurion 5 M20 GC (Device) | Food and Beverage | Cash or cash equivalent | $108.90 | General |
| Category: Medical Device | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: DIABETES | ||||||
| 11/08/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.03 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/07/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Transcatheter Heart Valves | ||||||
| 11/06/2024 | Philips North America LLC | (5153) Azurion 5 M20 GC (Device) | Food and Beverage | Cash or cash equivalent | $130.56 | General |
| Category: Medical Device | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.25 | General |
| Category: Cardiovascular | ||||||
| 10/29/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Genetic Disease | ||||||
| 10/28/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/21/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $110.64 | General |
| Category: Transcatheter Heart Valves | ||||||
| 10/14/2024 | Baxter Healthcare | Hillrom - Cardiac Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 10/04/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Cardiology | ||||||
| 10/04/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $467.00 | General |
| Category: Cardiology | ||||||
| 10/02/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Cardiology | ||||||
| 10/02/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $467.00 | General |
| Category: Cardiology | ||||||
| 10/01/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: Cardiology | ||||||
| 10/01/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Genetic Disease | ||||||
| 09/30/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $90.72 | General |
| Category: Transcatheter Heart Valves | ||||||
| 09/26/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $122.53 | General |
| Category: Cardiology | ||||||
| 09/26/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/20/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: Cardiology | ||||||
| 09/19/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: Cardiology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Sure Scan PAS | Medtronic Vascular, Inc. | $1,500 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 47 | 5,097 | 7,364 | $2.6M | $705,102 |
| 2022 | 34 | 3,781 | 5,827 | $2.0M | $598,332 |
| 2021 | 57 | 9,301 | 14,091 | $4.2M | $1.4M |
| 2020 | 54 | 10,881 | 16,611 | $4.9M | $1.6M |
Total Patients
29,060
Total Services
43,893
Medicare Billing
$4.2M
Procedure Codes
197
All Medicare Procedures & Services
197 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 536 | 562 | $618,200 | $192,630 | 31.2% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 536 | 1,120 | $311,360 | $103,132 | 33.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 459 | 512 | $430,080 | $77,574 | 18.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 349 | 1,448 | $188,240 | $61,178 | 32.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 392 | 392 | $153,272 | $47,475 | 31.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 331 | 441 | $110,691 | $39,319 | 35.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 533 | 560 | $165,200 | $27,520 | 16.7% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 124 | 129 | $105,283 | $24,163 | 23.0% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 45 | 48 | $73,200 | $21,466 | 29.3% |
| 33340 | Repair of left upper heart chamber with implant with review by radiologist | Facility | 2023 | 35 | 35 | $71,330 | $14,895 | 20.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 81 | 94 | $46,530 | $12,961 | 27.9% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 39 | 39 | $38,415 | $9,805 | 25.5% |
| 33361 | Replacement of aortic valve through the skin and femoral artery | Facility | 2023 | 13 | 13 | $39,273 | $7,587 | 19.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 41 | 71 | $18,034 | $6,717 | 37.2% |
| 78803 | Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | Office | 2023 | 21 | 21 | $18,606 | $6,007 | 32.3% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 15 | 15 | $37,800 | $5,955 | 15.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 472 | 479 | $27,303 | $5,259 | 19.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 30 | 30 | $14,580 | $5,132 | 35.2% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 46 | 46 | $21,666 | $4,722 | 21.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 16 | 25 | $16,700 | $4,230 | 25.3% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 64 | 98 | $8,232 | $4,220 | 51.3% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 68 | 143 | $12,870 | $3,344 | 26.0% |
| Q9957 | Injection, perflutren lipid microspheres, per ml | Office | 2023 | 41 | 69 | $10,005 | $2,341 | 23.4% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 23 | 104 | $7,488 | $2,152 | 28.7% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 22 | 22 | $8,297 | $1,854 | 22.3% |
About Dr. Michael Gen, M.D
Dr. Michael Gen, M.D is a Interventional Cardiology healthcare provider based in Virginia Beach, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487623906.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Gen, M.D has received a total of $362,343 in payments from pharmaceutical and medical device companies, with $40,084 received in 2024. These payments were reported across 1,458 transactions from 74 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($180,407).
As a Medicare-enrolled provider, Gen has provided services to 29,060 Medicare beneficiaries, totaling 43,893 services with total Medicare billing of $4.2M. Data is available for 4 years (2020–2023), covering 197 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Internal Medicine, Cardiovascular Disease
- Location Virginia Beach, VA
- Active Since 03/16/2006
- Last Updated 06/04/2025
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1487623906
Products in Payments
- Repatha (Biological) $164,638
- NORTHERA (Drug) $118,370
- JARDIANCE (Drug) $14,139
- PRALUENT (Drug) $9,946
- FARXIGA (Drug) $5,944
- CHANTIX (Drug) $5,364
- PRALUENT ALIROCUMAB INJECTION (Biological) $4,671
- Corlanor (Drug) $3,584
- ENTRESTO (Drug) $1,973
- SureScan (Device) $1,500
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $1,316
- Impella (Device) $1,272
- Micra (Device) $1,265
- Tendyne Mitral Valve System (Device) $1,087
- Vascepa (Drug) $951.69
- 3F (Device) $843.29
- SelectSecure (Device) $818.31
- XARELTO (Drug) $762.97
- Diamondback Coronary (Device) $563.73
- Barostim Neo System (Device) $557.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.